Egetis Therapeutics AB Stock
Stocks
EGTX
SE0003815604
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.000 SEK | -1.80% |
|
-10.71% | +12.36% |
| 07-19 | Certain Ordinary Shares of Egetis Therapeutics AB are subject to a Lock-Up Agreement Ending on 20-JUL-2026. | CI |
| 07-16 | Linc increased net asset value by 6 percent in the second quarter | FW |
| Market Cap | 2.79B 292M 254M 237M 217M 410M 27.92B 417M 1.09B 13.9B 1.1B 1.07B 46.61B | P/E 2026 * |
408x | P/E 2027 * | -18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.3B 241M 209M 195M 179M 338M 23B 343M 902M 11.45B 905M 885M 38.39B | EV / Sales 2026 * |
5.24x | EV / Sales 2027 * | 6.96x |
| Free-Float |
40.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Egetis Therapeutics AB
| 1 day | -1.80% | ||
| 1 week | -10.71% | ||
| 1 month | +1.69% | ||
| 3 months | +6.95% | ||
| 6 months | +15.61% | ||
| Current year | +12.36% |
| 1 week | 5.99 |  | 6.83 |
| 1 month | 5.63 | | 6.86 |
| Current year | 4.23 | | 7 |
| 1 year | 3.62 | | 7.07 |
| 3 years | 3.02 | | 9.3 |
| 5 years | 3 | | 9.3 |
| 10 years | 3 | | 50.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2017-06-15 | |
Yilmaz Mahshid
DFI | Director of Finance/CFO | 47 | 2017-12-30 |
Tiago Nune
CTO | Chief Tech/Sci/R&D Officer | - | 2026-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2016-12-31 | |
| Director/Board Member | 65 | 2016-12-31 | |
Mats Blom
CHM | Chairman | 61 | 2024-05-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/13/26 | Sell | Chief Executive Officer | -286,071 | 0.0724% | ||
| 5/11/26 | Fiscal year | Chief Financial Officer | 264,880 | 0.0670% | ||
| 1/16/26 | Buy | Chairman | 150,000 | 0.0380% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.80% | -10.71% | +8.89% | +37.14% | 292M | |
| +2.35% | +2.74% | +33.41% | +79.20% | 56.54B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.6B | |
| -2.44% | +1.40% | -15.74% | -16.80% | 22.91B | |
| -2.85% | -7.78% | -8.09% | +346.36% | 21.37B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 20.27B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.56B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.75B | |
| -5.25% | -4.23% | +46.41% | +169.05% | 13.33B | |
| +3.41% | -6.61% | +163.08% | +280.43% | 13.53B | |
| Average | -0.29% | -4.48% | +31.92% | +145.33% | 23.42B | |
| Weighted average by Cap. | +0.23% | -2.97% | +28.65% | +119.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 439M 46.01M 39.99M 37.22M 34.18M 64.54M 4.39B 65.54M 172M 2.19B 173M 169M 7.33B | 353M 36.98M 32.15M 29.93M 27.47M 51.88M 3.53B 52.69M 138M 1.76B 139M 136M 5.89B |
| Net income | 302M 31.7M 27.56M 25.65M 23.55M 44.48M 3.03B 45.17M 119M 1.51B 119M 116M 5.05B | -95.62M -10.03M -8.72M -8.11M -7.45M -14.06M -957M -14.28M -37.53M -476M -37.65M -36.82M -1.6B |
| Net Debt | -492M -51.61M -44.86M -41.76M -38.34M -72.4M -4.93B -73.52M -193M -2.45B -194M -190M -8.22B | -334M -35.02M -30.45M -28.34M -26.02M -49.14M -3.34B -49.9M -131M -1.66B -132M -129M -5.58B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | SEK 6.000 | -1.80% | 1,362,958 |
| 26-07-30 | SEK 6.110 | -2.40% | 601,757 |
| 26-07-29 | SEK 6.260 | -4.86% | 586,322 |
| 26-07-28 | SEK 6.580 | -2.08% | 261,578 |
| 26-07-27 | SEK 6.720 | -.--% | 304,162 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EGTX Stock
Select your edition
All financial news and data tailored to specific country editions
